Name: 글로벌 시장 동향
SKU: BT7187
Availability: InStock

보고서 요약(국문)

개요
글로벌 임상화학 분석기 시장은 2022년 YY억 달러에 도달했으며, 2023년부터 2030년까지 연평균 성장률(CAGR) YY%로 성장하여 2030년에는 YY억 달러에 이를 것으로 예상됩니다.
글로벌 임상화학 분석기 시장은 수년간 다양한 요인의 영향을 받으며 상당한 성장과 변화를 경험해 왔습니다. 임상화학 분석기는 자동화된 의료 실험실 장비의 핵심 구성 요소입니다. 이 장비는 혈액이나 소변과 같은 생체 시료의 성분을 분석하고 특성을 파악합니다. 이를 위해 첨단 화학적 또는 광학적 방법이 사용될 수 있지만, 이에 대해서는 잠시 후 자세히 살펴보겠습니다.
특히 개발도상국을 중심으로 한 정부의 신제품 출시 및 연구 개발은 첨단 완전 자동 또는 반자동 임상화학 분석기의 활용을 촉진하고 글로벌 임상화학 분석기 시장 성장을 견인할 것입니다. 이러한 혁신적인 화학 분석기는 탁상형과 바닥 설치형의 두 가지 유형으로 나뉩니다.

시장 동향: 성장 동력 및 제약 요인
협력 및 인수 증가
선진국들은 높은 투자, 소득 수준, 인프라 개발에 힘입어 의료 부문이 빠르게 발전하고 있습니다. 여러 국가에서 연구 활동 증가로 임상 화학 분석기에 대한 수요가 크게 증가했습니다. 다양한 국가 간의 협력, 인수, 기술 발전을 동반한 신제품 출시 등이 시장 성장을 견인하는 중요한 요인이 될 것입니다.
2023년 2월 2일, 의료기기 공급업체인 지멘스 헬스케어(Siemens Healthineers)와 진단 서비스 제공업체인 유니랩스(Unilabs)는 2억 유로 이상의 가치를 지닌 다년간 계약을 체결했습니다. 유니랩스는 지멘스 헬스케어의 최첨단 기술에 투자하고 400대 이상의 과학 분석기를 구매하여 실험실 인프라를 더욱 업그레이드하고 고객에게 최고의 서비스를 제공할 예정입니다.

또한, 2021년 2월 3일, MedTest Holdings, Inc.는 미국 어바인에 본사를 둔 HORIBA Instruments와 일본 교토에 본사를 둔 HORIBA, Ltd.에 인수되었습니다. 이 인수를 통해 HORIBA Medical은 Pointe Scientific과 MedTest의 우수한 화학 제품의 상호 보완적인 혁신 기술을 활용하면서 IVD 시장의 다양한 요구를 충족할 수 있게 되었습니다.
더불어, 새로운 기술과 다양한 연구 목적을 위한 여러 유형의 임상 화학 분석기의 활용도가 증가하고 있습니다. 만성 질환의 증가와 혁신적인 진단 제품 개발을 위한 연구 증가는 임상 화학 분석기 시장 성장을 견인하는 주요 요인이 될 것입니다.
임상 화학 분석기와 관련된 높은 비용
키트 또는 소모품 비용, 그리고 CPRT 비용은 임상 화학 실험실에서 구매하거나 사용할 장비 유형에 영향을 미치는 기준 중 일부이지만, 현대 임상 화학 실험실에서 사용되는 장비의 비용은 상당히 높습니다.
생화학 분석기는 상당한 초기 투자 비용이 필요합니다. 최고급 모델은 최대 45,000달러에 달할 수 있습니다. 높은 구매 가격 때문에 병원과 같은 사용자들은 임대 계약을 통해 장비를 구매할 수밖에 없으며, 이는 매출 감소로 이어집니다.
이 보고서에 대한 자세한 내용은 샘플을 요청하십시오.
세그먼트 분석
글로벌 임상 화학 분석기 시장은 제품 유형, 모달리티, 응용 분야, 최종 사용자 및 지역별로 세분화됩니다.
전자동 임상 화학 분석기 부문은 시장 점유율의 약 64%를 차지했습니다.
전자동 화학 분석기는 다양한 실험실 환경에서 분석 작업을 더욱 쉽고 효율적으로 수행할 수 있도록 해줍니다. 연구원들은 이러한 도구를 통해 매우 높은 정확도로 분석 결과를 얻을 수 있으며, 분석 보고서를 최단 시간 내에 받아볼 수 있습니다. 전자동 화학 분석기는 알부민, 포도당, 크레아티닌, 빌리루빈 또는 무기인과 같은 물질의 일상적인 검사를 포함한 다양한 진단 작업에 사용됩니다.

또한 지질, 치료제, 불법 약물 등을 평가하기 위한 분석에도 사용됩니다. 완전 자동화된 화학 분석기는 다양한 연구 작업을 더 빠르게 수행하고 최단 시간 내에 데이터를 제공할 수 있도록 해줍니다.
2023년 6월 8일, Mindray는 지능형 샘플 공급 모듈과 두 가지 최첨단 분석기(화학발광 면역 분석기 CL-8000i 및 최첨단 화학 분석기 BS-2800M)를 결합한 최신 제품인 M1000 면역 분석 통합 화학 솔루션을 출시했습니다. 출시 이후 이 솔루션은 높은 정확도, 효율성 및 내구성, 특히 실험 처리 시스템의 혁신적인 설계와 강력한 기능으로 고객으로부터 큰 호응과 찬사를 받았습니다.
지역별 시장 점유율
북미는 2022년 시장 점유율의 약 34%를 차지했습니다.
의료 분야에서 임상 화학 분석기에 대한 수요가 증가함에 따라 북미 제조업체는 사업 확장의 기회를 갖고 있습니다. 북미에는 많은 생산업체와 공급업체가 있으며, 이 지역의 빠른 경제 성장으로 산업 생산이 확대되어 임상 화학 분석기에 대한 수요가 증가하고 있습니다.
의료비 지출 증가, 연구 개발 확대, 기술 발전 및 다양한 제품 개발, 그리고 이 지역 전반에 걸친 바이오 제약 또는 생명공학 기업 설립 증가는 이 지역의 임상 화학 분석기 시장 점유율 성장에 기여하고 있습니다. 완전 자동 임상 화학 분석기와 같은 다양한 혁신 제품에 대한 인식이 높아짐에 따라 이 지역의 시장은 성장하고 있습니다. 앞서 언급한 요소들은 북미가 세계에서 차지하는 지배적인 위치를 더욱 뒷받침합니다.
북미는 미국을 중심으로 글로벌 임상 화학 분석기 시장에서 핵심적인 역할을 계속하고 있습니다. 인프라 개발 및 투자를 장려하는 정부 정책과 첨단 기술 발전에 대한 집중은 미국 내 임상 화학 분석기 수요를 촉진했습니다. 미국은 임상 화학 분석기 수요를 자극하는 여러 정책과 연구를 적극적으로 추진해 왔습니다.

COVID-19 영향 분석
2019년 말 발생한 COVID-19 팬데믹은 전 세계 산업, 특히 글로벌 임상화학 분석기 시장에 전례 없는 어려움을 초래했습니다. 각국이 봉쇄, 공급망 차질, 경제 활동 위축에 직면하면서 다양한 기기 설계를 주요 소비 대상으로 하는 제약 부문은 심각한 타격을 입었습니다. 2020년 초부터 시작된 팬데믹의 광범위한 봉쇄와 제한 조치는 전 세계적으로 여러 사업에 영향을 미쳤습니다.
주요 의료 및 생명공학 산업은 운영을 중단하고 COVID-19 관리에 집중하면서 임상화학 분석기 수요가 급감했습니다. 그러나 현재 여러 연구가 재개되었고 기업들은 고효율의 신제품을 다시 출시하기 시작했습니다. 전반적으로 팬데믹이 글로벌 임상화학 분석기 시장에 미치는 영향은 비교적 완만할 것으로 예상되며, 벤치탑 분석기와 같은 혁신적인 제품에 대한 지속적인 수요와 연구 개발로 인해 시장은 꾸준히 성장할 것으로 전망됩니다.

주요 개발 사항
• 2023년 7월 25일, 미국 식품의약국(FDA)은 베크만 쿨터 다이애그노스틱스의 새로운 자동 화학 분석기인 DxC 500 AU 화학 분석기를 승인했습니다. 이번 승인으로 베크만 쿨터는 임상 화학 분석 제품군을 확장하고 체외 진단 분야의 제품 혁신에 대한 지속적인 노력을 보여주고 있습니다. DxC 500 AU 화학 분석기는 실험실 운영을 간소화하고 중요한 임상 결정을 지원하기 위해 개발된 베크만 쿨터의 여러 신제품 중 하나로, 중소 규모 실험실에 적합합니다.

• 2023년 7월 20일, 지멘스 헬스케어의 아텔리카 체외 진단 포트폴리오에 새롭게 추가된 임상 화학 검사 또는 면역 분석용 아텔리카 CI 분석기가 FDA 승인을 획득하고 현재 전 세계 주요 시장에서 판매되고 있습니다. 향상된 검사 시간 예측 가능성, 최첨단 보고 기능, 맞춤형 안전 및 보안 조치 등 이 분석기가 제공하는 경쟁력 있는 이점은 검사량이 적거나 중간 정도인 실험실에 유용할 것입니다. 경쟁 환경
주요 글로벌 시장 참여 기업으로는 F. Hoffmann-La Roche Ltd, Beckman Coulter, Inc., HORIBA Medical, Siemens Healthcare Private Limited, Hitachi High-Tech Corporation, Thermo Fisher Scientific Inc., EKF Diagnostics Holdings plc, Abbott, Mindray Medical India Pvt. Ltd., Randox Laboratories Ltd. 등이 있습니다.
보고서 구매 이유

• 제품 유형, 방식, 적용 분야, 최종 사용자 및 지역별 글로벌 임상화학 분석기 시장 세분화를 시각화하고 주요 기업 및 주요 업체를 파악합니다.

• 트렌드 분석 및 공동 개발을 통해 사업 기회를 발굴합니다.

• 모든 세그먼트를 포함한 임상화학 분석기 시장 수준의 다양한 데이터가 담긴 Excel 데이터 시트를 제공합니다.

• 심층적인 질적 인터뷰와 연구를 바탕으로 종합적인 분석 결과를 담은 PDF 보고서를 제공합니다.

• 주요 기업의 핵심 제품 정보를 담은 Excel 파일 형태의 제품 맵핑을 제공합니다.

글로벌 임상화학 분석기 시장 보고서는 약 69개의 표, 66개의 그림, 그리고 186페이지 분량으로 구성됩니다.
대상 고객 (2023년 기준)
• 제조업체/구매자
• 산업 투자자/투자은행가
• 시장 조사 전문가
• 신흥 기업

보고서 요약(영어 원문)

Overview
Global clinical chemistry analyzers market reached US$ YY billion in 2022 and is expected to reach US$ YY billion by 2030, growing with a CAGR of YY% during the forecast period 2023-2030.
The global clinical chemistry analyzers market has witnessed significant growth and transformations over the years, with various factors influencing its dynamics. Clinical chemistry analyzers are crucial parts of automated medical laboratory equipment. These devices examine and characterize the fluid sample composition of biological samples like blood or urine. Advanced chemical or optical methods can be used to do this; however, more on that in a moment.
Government novel product launch and research, particularly in developing economies, will continue to drive utilization of advanced fully automatic clinical chemistry analyzers or semi-automatic clinical chemistry analyzers and boost the global clinical chemistry analyzers market. The respective innovative chemistry analyzers are in two modalities including bench-top and floor standing.
Market Dynamics: Drivers & Restraints
Growing collaborations and acquisitions
Developed economies have been witnessing rapid growth in betterment of their healthcare sectors, driven by high investments, income levels, and infrastructure development. Several countries have experienced substantial demand for clinical chemistry analyzers owing to the rising research. Various collaborations, acquisitions and product launches with technological advanecments among different countries will be a crucial factor driving the growth of the market.
On February 2, 2023, a multi-year arrangement with a value of more than €200 million was started by Siemens Healthineers, a renowned provider of medical equipment, and Unilabs, a renowned supplier of diagnostic services. Unilabs has invested in cutting-edge technology from Siemens Healthineers and will buy more than 400 scientific analyzers to further upgrade its laboratory infrastructure and provide its clients with unmatched service.
Additionally, on February 3, 2021, MedTest Holdings, Inc. has been purchased by the Irvine headquarters of HORIBA Instruments and the Kyoto, Japan headquarters of HORIBA, Ltd. Through this acquisition, HORIBA Medical will have the chance to serve the multidisciplinary needs of the IVD market while utilizing Pointe Scientific's and MedTest's superior Chemistry products' complimentary revolutionary technologies.
Furthermore, the rising utilization of novel technology and different types of clinical chemistry analyzers for the several research purposes. Rising chronic disorders and increasing research for innovative diagnostic product development will be a major factor driving the growth of the clinical chemistry analyzers market.
High cost associated with the clinical chemistry analyzers
Although the cost of kits or consumables, as well as the cost of the CPRT, are some of the criteria that may affect the type of instrument to be purchased or utilized in a clinical chemistry laboratory, the cost of the equipment in modern clinical chemistry laboratories is expensive.
Biochemistry analyzers involve a large initial investment; top-of-the-line models can cost up to $45,000. Because of their high acquisition prices, users like hospitals are forced to purchase them through rental agreements, which lowers sales.
For more details on this report - Request for Sample
Segment Analysis
The global clinical chemistry analyzers market is segmented based on product type, modality, application, end user and region.
Fully Automatic Clinical Chemistry Analyzers segment accounted for approximately 64% of market share
Fully automated chemical analyzers make it easier and more efficient to complete analytical tasks in various laboratory environments. Researchers can get evaluation results from these tools with exceptional precision. Get analysis reports in the shortest amount of time possible. A variety of diagnostic tasks are performed using fully automated chemical analyzers, including routine examination of albumin, glucose, creatinine, bilirubin, or inorganic phosphorus.
These are also employed in the execution of assays for the evaluation of lipids, therapeutic medications, illicit drugs, and more. Fully automated chemistry analyzers make it possible to do a variety of research tasks more quickly and deliver data in the shortest amount of time.
On June 8, 2023, the most recent offering from Mindray is the M1000 Chemistry with Immunoassay Integrated Solution, which combines an intelligent sample delivery module with two cutting-edge analyzers: the Chemiluminescence Immunoassay Analyzer CL-8000i and the state-of-the-art Chemistry Analyzer BS-2800M. Since its introduction, the solution has received a great deal of customer support and appreciation for its high degree of accuracy, effectiveness, and resilience, especially for the creative design and potent features of the experimental treatment system.
Geographical Penetration
North America accounted for around 34% of market share in 2022
Due to the rising need for clinical chemistry analyzers in healthcare, manufacturers in North America have chances of increasing their operations. There are many producers and suppliers in North America and owing to the quick economic growth of the region, industrial production has expanded, driving the demand for clinical chemistry analyzers.
Increasing expenditure on healthcare and rising research studies, advancement of technologies and different types of products, and increase in biopharmaceutical or biotechnology business establishment across the region are also contributing to the growth of clinical chemistry analyzers market share of this region. The market in this area is growing as people become more aware of various novel innovative products such as fully automatic clinical chemistry analyzers. The aforementioned elements further attest to North America's hegemonic position in the world.
North America continues to be a key player in the global clinical chemistry analyzers market, with United States leading the way. Government initiatives promoting infrastructure development and investment, and a focus on rising advancements have fueled the demand for clinical chemistry analyzers in the U.S. United States have been proactive in executing several initiatives or researches, stimulating clinical chemistry analyzers demand.
COVID-19 Impact Analysis
The outbreak of the COVID-19 pandemic in late 2019 created unprecedented challenges for industries worldwide, including the global clinical chemistry analyzers market. As countries grappled with lockdowns, supply chain disruptions and reduced economic activity, the pharmaceutical sector, with a significant consumer of various device designs, was significantly impacted. Several efforts all throughout the world were impacted by the pandemic's broad lockdowns and limitations that started in early 2020.
Major medical and biotechnology industries came to a standstill and shifted their attention towards the management of COVID-19, leading to a slump in demand for clinical chemistry analyzers. Now several research studies have been initiated and companies have again started launching novel products with high efficiency. Overall, the impact of the pandemic on the global clinical chemistry analyzers market is expected to be relatively moderate, with the market continuing to grow steadily due to the ongoing need and research for innovative products, like bench-top analyzers.
Key Developments
• On July 25, 2023, the FDA has approved Beckman Coulter Diagnostics' new automated chemistry analyzer, DxC 500 AU Chemistry Analyzer. This decision expands the company's clinical chemistry offering and shows its continued commitment to product innovation in the in vitro diagnostics sector. The DxC 500 AU Chemistry Analyzer, one of several new Beckman Coulter products created to streamline laboratory operations and assist crucial clinical decisions, is intended for small-to-medium-sized laboratories.
• On July 2o, 2023, the Atellica CI Analyzer for clinical chemistry testing or immunoassay, the newest addition to Siemens Healthineers' Atellica in vitro diagnostics portfolio, has acquired FDA clearance and is currently offered in many of the major markets across the world. The competitive benefits that the analyzer offers, such as enhanced turnaround time predictability, cutting-edge reporting features, and targeted safety and security measures, will be beneficial to labs operating at low to moderate testing volumes.
Competitive Landscape
The major global players in the market include F. Hoffmann-La Roche Ltd, Beckman Coulter, Inc., HORIBA Medical, Siemens Healthcare Private Limited, Hitachi High-Tech Corporation, Thermo Fisher Scientific Inc., EKF Diagnostics Holdings plc, Abbott, Mindray Medical India Pvt. Ltd. and Randox Laboratories Ltd. Among others.
Why Purchase the Report?
• To visualize the global clinical chemistry analyzers market segmentation based on product type, modality, application, end user and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of clinical chemistry analyzers market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global clinical chemistry analyzers market report would provide approximately 69 tables, 66 figures and 186 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Modality
3.3. Snippet by Application
3.4. Snippet by End User
3.5. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Growing collaborations and acquisitions
4.1.1.2. Rising technological advancements and developments
4.1.2. Restraints
4.1.2.1. High cost associated with the clinical chemistry analyzers
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. SWOT Analysis
5.6. Patent Analysis
5.7. Russia-Ukraine War Impact Analysis
5.8. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Product Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Fully Automatic Clinical Chemistry Analyzers*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Semi-Automatic Clinical Chemistry Analyzers
8. By Modality
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
8.1.2. Market Attractiveness Index, By Modality
8.2. Bench-Top Analyzers*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Floor-Standing Analyzers
9. By Application
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.1.2. Market Attractiveness Index, By Application
9.2. Clinical Diagnostics *
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Drug Testing
9.4. Others
10. By End User
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.1.2. Market Attractiveness Index, By End User
10.2. Hospitals*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Academic or Research Laboratories
10.4. Diagnostic Centers
10.5. Others
11. By Region
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.2.7.1. U.S.
11.2.7.2. Canada
11.2.7.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.3.7.1. Germany
11.3.7.2. UK
11.3.7.3. France
11.3.7.4. Italy
11.3.7.5. Spain
11.3.7.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.4.7.1. Brazil
11.4.7.2. Argentina
11.4.7.3. Rest of South America
11.5. Asia-Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.5.7.1. China
11.5.7.2. India
11.5.7.3. Japan
11.5.7.4. Australia
11.5.7.5. Rest of Asia-Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis
13. Company Profiles
13.1. F. Hoffmann-La Roche Ltd*
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Financial Overview
13.1.4. Key Developments
13.2. Beckman Coulter, Inc.
13.3. HORIBA Medical
13.4. Siemens Healthcare Private Limited
13.5. Hitachi High-Tech Corporation
13.6. Thermo Fisher Scientific Inc.
13.7. EKF Diagnostics Holdings plc
13.8. Abbott
13.9. Mindray Medical India Pvt. Ltd.
13.10. Randox Laboratories Ltd.
LIST NOT EXHAUSTIVE
14. Appendix
14.1. About Us and Services
14.2. Contact Us

언급된 주요 기업들

F. Hoffmann-La Roche Ltd, 4. Key Developments, Beckman Coulter, Inc., HORIBA Medical, Siemens Healthcare Private Limited, Hitachi High-Tech Corporation, Thermo Fisher Scientific Inc., EKF Diagnostics Holdings plc, Abbott, Mindray Medical India Pvt. Ltd., Randox Laboratories Ltd.

표 목록 (Tables)

List of Tables Table 1 Global Clinical Chemistry Analyzers Market Value, By Product Type, 2022, 2026 & 2030 (US$ Million)

Table 2 Global Clinical Chemistry Analyzers Market Value, By Modality, 2022, 2026 & 2030 (US$ Million)

Table 3 Global Clinical Chemistry Analyzers Market Value, By Application, 2022, 2026 & 2030 (US$ Million)

Table 4 Global Clinical Chemistry Analyzers Market Value, By End User, 2022, 2026 & 2030 (US$ Million)

Table 5 Global Clinical Chemistry Analyzers Market Value, By Region, 2022, 2026 & 2030 (US$ Million)

Table 6 Global Clinical Chemistry Analyzers Market Value, By Product Type, 2022, 2026 & 2030 (US$ Million)

Table 7 Global Clinical Chemistry Analyzers Market Value, By Product Type, 2021-2030 (US$ Million)

Table 8 Global Clinical Chemistry Analyzers Market Value, By Modality, 2022, 2026 & 2030 (US$ Million)

Table 9 Global Clinical Chemistry Analyzers Market Value, By Modality, 2021-2030 (US$ Million)

Table 10 Global Clinical Chemistry Analyzers Market Value, By Application, 2022, 2026 & 2030 (US$ Million)

Table 11 Global Clinical Chemistry Analyzers Market Value, By Application, 2021-2030 (US$ Million)

Table 12 Global Clinical Chemistry Analyzers Market Value, By End User, 2022, 2026 & 2030 (US$ Million)

Table 13 Global Clinical Chemistry Analyzers Market Value, By End User, 2021-2030 (US$ Million)

Table 14 Global Clinical Chemistry Analyzers Market Value, By Region, 2022, 2026 & 2030 (US$ Million)

Table 15 Global Clinical Chemistry Analyzers Market Value, By Region, 2021-2030 (US$ Million)

Table 16 North America Clinical Chemistry Analyzers Market Value, By Product Type, 2021-2030 (US$ Million)

Table 17 North America Clinical Chemistry Analyzers Market Value, By Modality, 2021-2030 (US$ Million)

Table 18 North America Clinical Chemistry Analyzers Market Value, By Application, 2021-2030 (US$ Million)

Table 19 North America Clinical Chemistry Analyzers Market Value, By End User, 2021-2030 (US$ Million)

Table 20 North America Clinical Chemistry Analyzers Market Value, By Country, 2021-2030 (US$ Million)

Table 21 South America Clinical Chemistry Analyzers Market Value, By Product Type, 2021-2030 (US$ Million)

Table 22 South America Clinical Chemistry Analyzers Market Value, By Modality, 2021-2030 (US$ Million)

Table 23 South America Clinical Chemistry Analyzers Market Value, By Application, 2021-2030 (US$ Million)

Table 24 South America Clinical Chemistry Analyzers Market Value, By End User, 2021-2030 (US$ Million)

Table 25 South America Clinical Chemistry Analyzers Market Value, By Country, 2021-2030 (US$ Million)

Table 26 Europe Clinical Chemistry Analyzers Market Value, By Product Type, 2021-2030 (US$ Million)

Table 27 Europe Clinical Chemistry Analyzers Market Value, By Modality, 2021-2030 (US$ Million)

Table 28 Europe Clinical Chemistry Analyzers Market Value, By Application, 2021-2030 (US$ Million)

Table 29 Europe Clinical Chemistry Analyzers Market Value, By End User, 2021-2030 (US$ Million)

Table 30 Europe Clinical Chemistry Analyzers Market Value, By Country, 2021-2030 (US$ Million)

Table 31 Asia-Pacific Clinical Chemistry Analyzers Market Value, By Product Type, 2021-2030 (US$ Million)

Table 32 Asia-Pacific Clinical Chemistry Analyzers Market Value, By Modality, 2021-2030 (US$ Million)

Table 33 Asia-Pacific Clinical Chemistry Analyzers Market Value, By Application, 2021-2030 (US$ Million)

Table 34 Asia-Pacific Clinical Chemistry Analyzers Market Value, By End User, 2021-2030 (US$ Million)

Table 35 Asia-Pacific Clinical Chemistry Analyzers Market Value, By Country, 2021-2030 (US$ Million)

Table 36 Middle East & Africa Clinical Chemistry Analyzers Market Value, By Product Type, 2021-2030 (US$ Million)

Table 37 Middle East & Africa Clinical Chemistry Analyzers Market Value, By Modality, 2021-2030 (US$ Million)

Table 38 Middle East & Africa Clinical Chemistry Analyzers Market Value, By Application, 2021-2030 (US$ Million)

Table 39 Middle East & Africa Clinical Chemistry Analyzers Market Value, By End User, 2021-2030 (US$ Million)

Table 40 F. Hoffmann-La Roche Ltd: Overview

Table 41 F. Hoffmann-La Roche Ltd: Product Portfolio

Table 42 F. Hoffmann-La Roche Ltd: Key Developments

Table 43 Beckman Coulter, Inc.: Overview

Table 44 Beckman Coulter, Inc.: Product Portfolio

Table 45 Beckman Coulter, Inc.: Key Developments

Table 46 HORIBA Medical: Overview

Table 47 HORIBA Medical: Product Portfolio

Table 48 HORIBA Medical: Key Developments

Table 49 Siemens Healthcare Private Limited: Overview

Table 50 Siemens Healthcare Private Limited: Product Portfolio

Table 51 Siemens Healthcare Private Limited: Key Developments

Table 52 Hitachi High-Tech Corporation: Overview

Table 53 Hitachi High-Tech Corporation: Product Portfolio

Table 54 Hitachi High-Tech Corporation: Key Developments

Table 55 Thermo Fisher Scientific Inc.: Overview

Table 56 Thermo Fisher Scientific Inc.: Product Portfolio

Table 57 Thermo Fisher Scientific Inc.: Key Developments

Table 58 EKF Diagnostics Holdings plc: Overview

Table 59 EKF Diagnostics Holdings plc: Product Portfolio

Table 60 EKF Diagnostics Holdings plc: Key Developments

Table 61 Abbott: Overview

Table 62 Abbott: Product Portfolio

Table 63 Abbott: Key Developments

Table 64 Mindray Medical India Pvt. Ltd.: Overview

Table 65 Mindray Medical India Pvt. Ltd.: Product Portfolio

Table 66 Mindray Medical India Pvt. Ltd.: Key Developments

Table 67 Randox Laboratories Ltd.: Overview

Table 68 Randox Laboratories Ltd.: Product Portfolio

Table 69 Randox Laboratories Ltd.: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Clinical Chemistry Analyzers Market Value, 2021-2030 (US$ Million)

Figure 2 Global Clinical Chemistry Analyzers Market Share, By Product Type, 2022 & 2030 (%)

Figure 3 Global Clinical Chemistry Analyzers Market Share, By Modality, 2022 & 2030 (%)

Figure 4 Global Clinical Chemistry Analyzers Market Share, By Application, 2022 & 2030 (%)

Figure 5 Global Clinical Chemistry Analyzers Market Share, By End User, 2022 & 2030 (%)

Figure 6 Global Clinical Chemistry Analyzers Market Share, By Region, 2022 & 2030 (%)

Figure 7 Global Clinical Chemistry Analyzers Market Y-o-Y Growth, By Product Type, 2022-2030 (%)

Figure 8 Fully Automatic Clinical Chemistry Analyzers Clinical Chemistry Analyzers Market Value, 2021-2030 (US$ Million)

Figure 9 Semi-Automatic Clinical Chemistry Analyzers Clinical Chemistry Analyzers Market Value, 2021-2030 (US$ Million)

Figure 10 Global Clinical Chemistry Analyzers Market Y-o-Y Growth, By Modality, 2022-2030 (%)

Figure 11 Bench-Top Analyzers Modality in Global Clinical Chemistry Analyzers Market Value, 2021-2030 (US$ Million)

Figure 12 Floor-Standing Analyzers Modality in Global Clinical Chemistry Analyzers Market Value, 2021-2030 (US$ Million)

Figure 13 Global Clinical Chemistry Analyzers Market Y-o-Y Growth, By Application, 2022-2030 (%)

Figure 14 Clinical Diagnostics Application in Global Clinical Chemistry Analyzers Market Value, 2021-2030 (US$ Million)

Figure 15 Drug Testing Application in Global Clinical Chemistry Analyzers Market Value, 2021-2030 (US$ Million)

Figure 16 Others Application in Global Clinical Chemistry Analyzers Market Value, 2021-2030 (US$ Million)

Figure 17 Global Clinical Chemistry Analyzers Market Y-o-Y Growth, By End User, 2022-2030 (%)

Figure 18 Hospitals End User in Global Clinical Chemistry Analyzers Market Value, 2021-2030 (US$ Million)

Figure 19 Academic or Research Laboratories End User in Global Clinical Chemistry Analyzers Market Value, 2021-2030 (US$ Million)

Figure 20 Diagnostic Centers End User in Global Clinical Chemistry Analyzers Market Value, 2021-2030 (US$ Million)

Figure 21 Others End User in Global Clinical Chemistry Analyzers Market Value, 2021-2030 (US$ Million)

Figure 22 Global Clinical Chemistry Analyzers Market Y-o-Y Growth, By Region, 2022-2030 (%)

Figure 23 North America Clinical Chemistry Analyzers Market Value, 2021-2030 (US$ Million)

Figure 24 Asia-Pacific Clinical Chemistry Analyzers Market Value, 2021-2030 (US$ Million)

Figure 25 Europe Clinical Chemistry Analyzers Market Value, 2021-2030 (US$ Million)

Figure 26 South America Clinical Chemistry Analyzers Market Value, 2021-2030 (US$ Million)

Figure 27 Middle East and Africa Clinical Chemistry Analyzers Market Value, 2021-2030 (US$ Million)

Figure 28 North America Clinical Chemistry Analyzers Market Value, 2021-2030 (US$ Million)

Figure 29 North America Clinical Chemistry Analyzers Market Share, By Product Type, 2022 & 2030 (%)

Figure 30 North America Clinical Chemistry Analyzers Market Share, By Modality, 2022 & 2030 (%)

Figure 31 North America Clinical Chemistry Analyzers Market Share, By Application, 2022 & 2030 (%)

Figure 32 North America Clinical Chemistry Analyzers Market Share, By End User, 2022 & 2030 (%)

Figure 33 North America Clinical Chemistry Analyzers Market Share, By Country, 2022 & 2030 (%)

Figure 34 South America Clinical Chemistry Analyzers Market Value, 2021-2030 (US$ Million)

Figure 35 South America Clinical Chemistry Analyzers Market Share, By Product Type, 2022 & 2030 (%)

Figure 36 South America Clinical Chemistry Analyzers Market Share, By Modality, 2022 & 2030 (%)

Figure 37 South America Clinical Chemistry Analyzers Market Share, By Application, 2022 & 2030 (%)

Figure 38 South America Clinical Chemistry Analyzers Market Share, By End User, 2022 & 2030 (%)

Figure 39 South America Clinical Chemistry Analyzers Market Share, By Country, 2022 & 2030 (%)

Figure 40 Europe Clinical Chemistry Analyzers Market Value, 2021-2030 (US$ Million)

Figure 41 Europe Clinical Chemistry Analyzers Market Share, By Product Type, 2022 & 2030 (%)

Figure 42 Europe Clinical Chemistry Analyzers Market Share, By Modality, 2022 & 2030 (%)

Figure 43 Europe Clinical Chemistry Analyzers Market Share, By Application, 2022 & 2030 (%)

Figure 44 Europe Clinical Chemistry Analyzers Market Share, By End User, 2022 & 2030 (%)

Figure 45 Europe Clinical Chemistry Analyzers Market Share, By Country, 2022 & 2030 (%)

Figure 46 Asia-Pacific Clinical Chemistry Analyzers Market Value, 2021-2030 (US$ Million)

Figure 47 Asia-Pacific Clinical Chemistry Analyzers Market Share, By Product Type, 2022 & 2030 (%)

Figure 48 Asia-Pacific Clinical Chemistry Analyzers Market Share, By Modality, 2022 & 2030 (%)

Figure 49 Asia-Pacific Clinical Chemistry Analyzers Market Share, By Application, 2022 & 2030 (%)

Figure 50 Asia-Pacific Clinical Chemistry Analyzers Market Share, By End User, 2022 & 2030 (%)

Figure 51 Asia-Pacific Clinical Chemistry Analyzers Market Share, By Country, 2022 & 2030 (%)

Figure 52 Middle East & Africa Clinical Chemistry Analyzers Market Value, 2021-2030 (US$ Million)

Figure 53 Middle East & Africa Clinical Chemistry Analyzers Market Share, By Product Type, 2022 & 2030 (%)

Figure 54 Middle East & Africa Clinical Chemistry Analyzers Market Share, By Modality, 2022 & 2030 (%)

Figure 55 Middle East & Africa Clinical Chemistry Analyzers Market Share, By Application, 2022 & 2030 (%)

Figure 56 Middle East & Africa Clinical Chemistry Analyzers Market Share, By End User, 2022 & 2030 (%)

Figure 57 F. Hoffmann-La Roche Ltd: Financials

Figure 58 Beckman Coulter, Inc.: Financials

Figure 59 HORIBA Medical: Financials

Figure 60 Siemens Healthcare Private Limited: Financials

Figure 61 Hitachi High-Tech Corporation: Financials

Figure 62 Thermo Fisher Scientific Inc.: Financials

Figure 63 EKF Diagnostics Holdings plc: Financials

Figure 64 Abbott: Financials

Figure 65 Mindray Medical India Pvt. Ltd.: Financials

Figure 66 Randox Laboratories Ltd.: Financials

글로벌 임상화학 분석기 시장 – 2023-2030

Global Clinical Chemistry Analyzers Market -2023-2030